Literature DB >> 10861038

An amiloride-sensitive and voltage-dependent Na+ channel in an HLA-DR-restricted human T cell clone.

Z F Lai1, Y Z Chen, Y Nishimura, K Nishi.   

Abstract

We investigated changes in voltage-gated Na+ currents and effects of extracellular Na+ on proliferation in HLA-DR-restricted human CD4+ alphabeta T cells after stimulation with a non-self antigenic peptide, M12p54-68. In the absence of antigenic peptide, neither single (n = 80) nor APC-contacted (n = 71) T cells showed voltage-gated inward currents recording with whole-cell patch-clamp techniques, even with Ca2+ and Na+ ions present in the perfusion solution. However, with the same recording conditions, 31% (26 of 84) of APC-contacted T cells stimulated with the antigenic peptide showed voltage-dependent inward currents that were elicited from -60 mV. The inward currents were not inhibited in extracellular Ca2+-free conditions or in the presence of 1 mM NiCl2. However, they were completely inhibited in extracellular Na+-free conditions, which were made by replacing Na+ with iso-osmotic N-methyl-d -glucamine or choline. The Na+ currents were insensitive to tetrodotoxin, a classical blocker of Na+ channels, but were dose-dependently inhibited by amiloride, a potassium-sparing pyrazine diuretic. Furthermore, the Ag-specific proliferative response of T cells was completely inhibited in Na+-free Tyrode's solution and was suppressed by amiloride in a dose-dependent manner. Our findings suggest that activation of amiloride-sensitive and voltage-gated Na+ channels would be an important step to allow an adequate influx of Na+ and maintain a sustained high Ca2+ level during T cell activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861038     DOI: 10.4049/jimmunol.165.1.83

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Targeting ion channels for the treatment of autoimmune neuroinflammation.

Authors:  Stefan Bittner; Sven G Meuth
Journal:  Ther Adv Neurol Disord       Date:  2013-09       Impact factor: 6.570

2.  Effect of malnutrition on K+ current in T lymphocytes.

Authors:  Rafael Godínez Fernández; Joaquín Azpiroz Leehan; Reyna Fierro Pastrana; Rocío Ortíz Muñiz
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

Review 3.  Sodium channels in astroglia and microglia.

Authors:  Laura W Pappalardo; Joel A Black; Stephen G Waxman
Journal:  Glia       Date:  2016-02-26       Impact factor: 7.452

Review 4.  Ion channels in innate and adaptive immunity.

Authors:  Stefan Feske; Heike Wulff; Edward Y Skolnik
Journal:  Annu Rev Immunol       Date:  2015       Impact factor: 28.527

5.  Loss of Na+ channel beta2 subunits is neuroprotective in a mouse model of multiple sclerosis.

Authors:  Heather A O'Malley; Andrew B Shreiner; Gwo-Hsiao Chen; Gary B Huffnagle; Lori L Isom
Journal:  Mol Cell Neurosci       Date:  2008-11-01       Impact factor: 4.314

6.  Axonal protection achieved in a model of multiple sclerosis using lamotrigine.

Authors:  David A Bechtold; Sandra J Miller; Angela C Dawson; Yue Sun; Raju Kapoor; David Berry; Kenneth J Smith
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

7.  Serotonin-mediated tuning of human helper T cell responsiveness to the chemokine CXCL12.

Authors:  Elena Magrini; Ildikò Szabò; Andrea Doni; Javier Cibella; Antonella Viola
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

8.  Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic mice.

Authors:  Alexei von Delwig; Catharien M U Hilkens; Daniel M Altmann; Rikard Holmdahl; John D Isaacs; Clifford V Harding; Helen Robertson; Norman McKie; John H Robinson
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

9.  Nebulized Lidocaine in COVID-19, An Hypothesis.

Authors:  Ziad A Ali; Rif S El-Mallakh
Journal:  Med Hypotheses       Date:  2020-06-01       Impact factor: 1.538

Review 10.  Sodium channels and multiple sclerosis: roles in symptom production, damage and therapy.

Authors:  Kenneth J Smith
Journal:  Brain Pathol       Date:  2007-04       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.